Results 181 to 190 of about 35,016 (265)

Osteoradionecrosis After Modern Radiotherapy for Oral Cavity Cancer: Incidence and Risk Factors

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
This retrospective single‐institution review evaluated contemporary ORN rates in 172 patients with oral cavity squamous cell carcinoma treated exclusively with IMRT (2013–2022). Reported osteoradionecrosis (ORN) incidence after head and neck cancer IMRT is relatively low, however, the 3 year ORN incidence was 24% in this cohort and increased incidence ...
Alyssa Farley, Taylor Petery, Nigel Dick, Jonathan Sackett, Jordan Kharofa, Vinita Takiar   +5 more
wiley   +1 more source

An interpretable machine learning model based on CT imaging for predicting lymphovascular invasion and survival in bladder urothelial carcinoma: a multicenter study. [PDF]

BMC Med Imaging
Xiao B, Zeng Q, Peng X, He Q, Xv Y, Wei Z, Xv Q, Lv F, Jiang Q, Wei S, Xiao M.   +10 more
europepmc   +1 more source

Smoking Status and Recurrence in Oral Tongue Squamous Cell Carcinoma: Evidence for Convergent Clinical Behavior

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
We evaluated the association between smoking history and disease‐free survival in two independent oral tongue squamous cell carcinoma (SCCOT) cohorts totaling 496 patients treated at MD Anderson Cancer Center. Smoking status and cumulative smoking exposure were not independently associated with recurrence risk in either cohort across Kaplan–Meier and ...
Jaafar A. Hadi, Guojun Li, Zohra N. Nizami, Jennifer Wang, Bridget Reeves, Ratna Veeramachaneni, Dianna Roberts, Lorena Isabel Gomez, Humam Kadara, Mena Mansour, Jeffrey N. Myers   +10 more
wiley   +1 more source

Lymphovascular Invasion Is a Predictor of Clinical Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy. [PDF]

J Clin Med
Dulf DV, Burnar AL, Dulf PL, Matei DR, Hendea RM, Andraș I, Grecea M, Bungărdean C, De Leo A, Ciuleanu TE, Crișan N, Coada CA.   +11 more
europepmc   +1 more source

Gastric Cancer: Pathobiology and Therapeutics

MedComm, Volume 7, Issue 6, June 2026.
Gastric cancer is a multistep process driven by the interplay of microbial virulence, host epithelial injury, and evolving molecular reprogramming. Initiation involves pathogen‐induced epigenetic alterations and the early subversion of key oncogenic signaling networks, facilitating the transition from chronic injury to metaplasia and malignant ...
Ruixian Yu, Miao Zhang, Yan Meng, Chunxiao Zhu, Weihong Zhang, Hui Zhang, Zhifa Cao, Meihang Du, Zhangting Zhao, Junping Bai, Yi Han, Yang Tang, Wei Kang, Ka Fai To, Shi Jiao, Liwei An, Zhaocai Zhou   +16 more
wiley   +1 more source

Prediction of lymphovascular invasion in non-mass enhancement breast cancer using DCE-MRI and clinical-pathological features. [PDF]

Front Oncol
Guo S, Zhao K, Xu H, Xie Y, Li Q, Liang J, Chen S, Sun J, Gao Z, Zhu L, Wang J.   +10 more
europepmc   +1 more source

The Tumor Immune Microenvironment in Endometrial Cancer: Composition, Molecular Subtypes, and Therapeutic Implications

MedComm – Oncology, Volume 5, Issue 2, June 2026.
Endometrial cancer (EC), a major gynecologic malignancy and a representative “cold tumor”, exhibits a tumor immune microenvironment (TIME) influenced by a broad range of cellular and molecular elements, immunosuppressive signals, and pathways of immune evasion.
Jingxuan Ye, Yashi Shi, Alexander Mustea, Xiaodan Mao, Pengming Sun   +4 more
wiley   +1 more source

CT based quantification of intratumoral and peritumoral heterogeneity for diagnosing lymphovascular invasion for early stage non-small cell lung cancer. [PDF]

BMC Med Imaging
Long Y, Zhang H, Guo Y, Gan T, Wang J, Li T, Zhang K, Chen J, Yang L, Liao M, Xiao F.   +10 more
europepmc   +1 more source

Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma: A matched cohort analysis

Precision Radiation Oncology, Volume 10, Issue 2, Page 155-164, June 2026.
Neoadjuvant chemoradiotherapy (NCRT) significantly improves overall survival over adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma, with comparable progression‐free survival and toxicity. This propensity‐matched study supports NCRT as the preferred strategy for this high‐risk population.
Mingqiang Lin, Yilin Yu, Yibing Hu, Rong Zheng, Jiancheng Li, Qiwei Yao   +5 more
wiley   +1 more source